Trinity Biotech plc (TRIB) is a Healthcare · Medical Devices company listed on NASDAQ. Price $7.23 (-0.48%), Market cap $0.01B, 52-week low–high $0.11 ~ $1.54.
Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosi
Financial statements, price targets, institutional (13F) holdings and related news for Trinity Biotech plc are updated in real time on BlackAll Trade.
Trinity Biotech plc trades at $7.23 (-0.48%). Real-time quotes and charts are available on BlackAll Trade.
Trinity Biotech plc has a market cap of about $0.01B.
Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of